301080 百普赛斯
已收盘 07-03 15:00:00
资讯
新帖
简况
百普赛斯（301080）披露回购股份事项前十名股东持股情况公告，7月2日股价下跌3.44%
证券之星 · 07-02
百普赛斯（301080）披露回购股份事项前十名股东持股情况公告，7月2日股价下跌3.44%
百普赛斯（301080）披露回购公司股份方案的公告，6月30日股价上涨0.52%
证券之星 · 06-30
百普赛斯（301080）披露回购公司股份方案的公告，6月30日股价上涨0.52%
百普赛斯最新公告：拟2500万元至5000万元回购股份用于注销
证券之星 · 06-29
百普赛斯最新公告：拟2500万元至5000万元回购股份用于注销
6月29日百普赛斯涨9.22%，圆信永丰医药健康A基金重仓该股
证券之星 · 06-29
6月29日百普赛斯涨9.22%，圆信永丰医药健康A基金重仓该股
百普赛斯涨9.22%，东海证券二个月前给出“买入”评级
证券之星 · 06-29
百普赛斯涨9.22%，东海证券二个月前给出“买入”评级
6月24日百普赛斯涨7.63%，圆信永丰医药健康A基金重仓该股
证券之星 · 06-24
6月24日百普赛斯涨7.63%，圆信永丰医药健康A基金重仓该股
每周股票复盘：百普赛斯（301080）调整激励计划价格及数量
证券之星 · 06-21
每周股票复盘：百普赛斯（301080）调整激励计划价格及数量
新股消息 | 百普赛斯(301080.SZ)拟港股IPO 中国证监会要求补充说明境外子公司涉及的境外投资等监管程序履行情况
智通财经 · 05-29
新股消息 | 百普赛斯(301080.SZ)拟港股IPO 中国证监会要求补充说明境外子公司涉及的境外投资等监管程序履行情况
百普赛斯（301080）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，5月22日股价下跌0.82%
证券之星 · 05-22
百普赛斯（301080）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，5月22日股价下跌0.82%
百普赛斯：公司聚焦生命科学、大健康领域
证券日报网 · 05-13
百普赛斯：公司聚焦生命科学、大健康领域
百普赛斯（301080）2026年一季报简析：营收净利润同比双双增长
证券之星 · 04-22
百普赛斯（301080）2026年一季报简析：营收净利润同比双双增长
百普赛斯（301080）披露2025年年度报告，4月20日股价下跌1.17%
证券之星 · 04-20
百普赛斯（301080）披露2025年年度报告，4月20日股价下跌1.17%
百普赛斯(301080.SZ)发布一季度业绩，归母净利润4625.71万元，增长13.99%
智通财经 · 04-20
百普赛斯(301080.SZ)发布一季度业绩，归母净利润4625.71万元，增长13.99%
4月3日百普赛斯跌6.08%，广发稳健回报混合A基金重仓该股
证券之星 · 04-03
4月3日百普赛斯跌6.08%，广发稳健回报混合A基金重仓该股
股市必读：百普赛斯（301080）今年截至3月23日累计跌幅已超25%
证券之星 · 03-24
股市必读：百普赛斯（301080）今年截至3月23日累计跌幅已超25%
股市必读：百普赛斯（301080）今年截至3月19日累计跌幅已超20%
证券之星 · 03-20
股市必读：百普赛斯（301080）今年截至3月19日累计跌幅已超20%
百普赛斯冲刺港股：9个月营收6亿利润1.3亿 陈宜顶控制41%股权
雷递网 · 02-06
百普赛斯冲刺港股：9个月营收6亿利润1.3亿 陈宜顶控制41%股权
2月2日百普赛斯跌6.52%，广发稳健回报混合A基金重仓该股
证券之星 · 02-02
2月2日百普赛斯跌6.52%，广发稳健回报混合A基金重仓该股
百普赛斯（301080）披露2025年度业绩预告，1月29日股价下跌1.15%
证券之星 · 01-29
百普赛斯（301080）披露2025年度业绩预告，1月29日股价下跌1.15%
百普赛斯(301080.SZ)发预增，预计2025年度归母净利润1.6亿元至1.9亿元，同比增长29.21%至53.43%
智通财经 · 01-29
百普赛斯(301080.SZ)发预增，预计2025年度归母净利润1.6亿元至1.9亿元，同比增长29.21%至53.43%
加载更多
公司概况
公司名称：
北京百普赛斯生物科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2021-10-18
主营业务：
北京百普赛斯生物科技股份有限公司的主营业务是专业提供重组蛋白、抗体等关键生物试剂产品及技术服务。公司的主要产品是重组蛋白、技术服务、抗体、试剂盒、磁珠。
发行价格：
112.50
{"stockData":{"symbol":"301080","market":"SZ","secType":"STK","nameCN":"百普赛斯","latestPrice":48.89,"timestamp":1783062225000,"preClose":47.41,"halted":0,"volume":5627203,"delay":0,"changeRate":0.0312,"floatShares":126000000,"shares":167000000,"eps":1.0244,"marketStatus":"已收盘","change":1.48,"latestTime":"07-03 15:00:00","open":48.15,"high":49.49,"low":47.8,"amount":274000000,"amplitude":0.0356,"askPrice":48.89,"askSize":25,"bidPrice":48.88,"bidSize":17,"shortable":0,"etf":0,"ttmEps":1.0244,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"adjPreClose":47.41,"symbolType":"stock","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":52.15,"lowLimit":42.67,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":167177695,"isCdr":false,"pbRate":2.93,"roa":"--","peRate":47.725498,"roe":"1.73%","epsLYR":0.9889,"committee":-0.435897,"marketValue":8173000000,"turnoverRate":0.0445,"status":0,"floatMarketCap":6177000000},"requestUrl":"/m/hq/s/301080","defaultTab":"news","newsList":[{"id":"2648506165","title":"百普赛斯（301080）披露回购股份事项前十名股东持股情况公告，7月2日股价下跌3.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648506165","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648506165?lang=zh_cn&edition=full","pubTime":"2026-07-02 17:48","pubTimestamp":1782985688,"startTime":"0","endTime":"0","summary":"截至2026年7月2日收盘，百普赛斯报收于47.41元，较前一交易日下跌3.44%，最新总市值为79.26亿元。该股当日开盘48.07元，最高49.86元，最低47.36元，成交额达2.47亿元，换手率为4.05%。百普赛斯于近日披露《关于回购股份事项前十名股东及前十名无限售条件股东持股情况的公告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200030501.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647344785","title":"百普赛斯（301080）披露回购公司股份方案的公告，6月30日股价上涨0.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647344785","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647344785?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:54","pubTimestamp":1782813241,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，百普赛斯报收于48.0元，较前一交易日上涨0.52%，最新总市值为80.25亿元。近日，北京百普赛斯生物科技股份有限公司披露《关于回购公司股份方案的公告》。本次回购股份将用于注销并减少注册资本。预计回购股份数量为416,667至833,333股，占公司当前总股本的0.25%至0.50%。回购实施期限为股东会审议通过之日起6个月内。本次回购不会对公司的经营、财务、债务履行能力及持续经营能力造成重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647537956","title":"百普赛斯最新公告：拟2500万元至5000万元回购股份用于注销","url":"https://stock-news.laohu8.com/highlight/detail?id=2647537956","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647537956?lang=zh_cn&edition=full","pubTime":"2026-06-29 19:49","pubTimestamp":1782733781,"startTime":"0","endTime":"0","summary":"百普赛斯(301080.SZ)公告称，公司拟使用自有资金和自筹资金以集中竞价方式回购股份，回购资金总额不低于2500万元且不超过5000万元，回购价格不超过60元/股。回购股份将用于注销并减少注册资本，实施期限自股东会审议通过之日起6个月内。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900035106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322190","title":"6月29日百普赛斯涨9.22%，圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322190","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322190?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:53","pubTimestamp":1782723231,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日百普赛斯涨9.22%，收盘报47.75元，换手率8.01%，成交量10.1万手，成交额4.66亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.66亿元，最新净值1.6714，较上一交易日下跌4.03%，近一年下跌3.56%。圆信永丰医药健康A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","150219","09939","159938","BK0216","BK1574","301080","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647322155","title":"百普赛斯涨9.22%，东海证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2647322155","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647322155?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:53","pubTimestamp":1782723222,"startTime":"0","endTime":"0","summary":"今日百普赛斯涨9.22%，收盘报47.75元。2026年4月24日，东海证券研究员杜永宏,付婷发布了对百普赛斯的研报《公司简评报告：国内外业务快速增长，业绩符合预期》，该研报对百普赛斯给出“买入”评级。公司持续加大研发投入，国内外业务均保持快速增长， 维持“买入” 评级。百普赛斯个股概况：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645789506","title":"6月24日百普赛斯涨7.63%，圆信永丰医药健康A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645789506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645789506?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:49","pubTimestamp":1782290974,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日百普赛斯涨7.63%，收盘报44.57元，换手率6.63%，成交量8.36万手，成交额3.62亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共11家，其中持有数量最多的公募基金为圆信永丰基金的圆信永丰医药健康A。圆信永丰医药健康A目前规模为2.66亿元，最新净值1.7774，较上一交易日上涨1.03%，近一年上涨4.6%。圆信永丰医药健康A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159938","BK0216","09939","150219","301080","BK1161","BK1574","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645095222","title":"每周股票复盘：百普赛斯（301080）调整激励计划价格及数量","url":"https://stock-news.laohu8.com/highlight/detail?id=2645095222","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645095222?lang=zh_cn&edition=full","pubTime":"2026-06-21 02:19","pubTimestamp":1781979549,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，百普赛斯报收于40.39元，较上周的37.16元上涨8.69%。公司公告汇总北京百普赛斯生物科技股份有限公司于2026年6月17日召开第二届董事会第二十七次会议，审议通过关于调整2025年限制性股票激励计划及股票增值权激励计划权益价格及数量的议案。因3名激励对象离职及相同业绩原因，作废股票增值权8.8854万份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639796624","title":"新股消息 | 百普赛斯(301080.SZ)拟港股IPO 中国证监会要求补充说明境外子公司涉及的境外投资等监管程序履行情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2639796624","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639796624?lang=zh_cn&edition=full","pubTime":"2026-05-29 19:26","pubTimestamp":1780053971,"startTime":"0","endTime":"0","summary":"中国证监会国际司共对11家企业出具补充材料要求。其中，要求百普赛斯补充说明公司境外子公司涉及的境外投资、外汇管理等监管程序具体履行情况。据港交所1月26日披露，北京百普赛斯生物科技股份有限公司向港交所主板递交上市申请书，招商证券国际为其独家保荐人。招股书显示，百普赛斯是全球生命科学工具及技术服务提供商，致力于赋能生物制药公司覆盖研发、生产及临床应用的全价值链。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447931.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IPOS","BK0216","301080","VXUS","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637904043","title":"百普赛斯（301080）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，5月22日股价下跌0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637904043","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637904043?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:37","pubTimestamp":1779442640,"startTime":"0","endTime":"0","summary":"近日，北京百普赛斯生物科技股份有限公司发布《关于向2025年限制性股票激励计划激励对象授予预留限制性股票的公告》。公告显示，公司于2026年5月21日召开董事会，确定向2025年限制性股票激励计划的54名激励对象授予预留限制性股票，授予日为2026年5月21日，授予数量为33.78万股，占公司股本总额的0.2021%，授予价格为17.91元/股，激励工具为第二类限制性股票。本次授予完成后，预留部分剩余2.2108万股作废失效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200033101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635373782","title":"百普赛斯：公司聚焦生命科学、大健康领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2635373782","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635373782?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:44","pubTimestamp":1778672640,"startTime":"0","endTime":"0","summary":"证券日报网讯5月13日，百普赛斯在互动平台回答投资者提问时表示，公司聚焦生命科学、大健康领域，提供重组蛋白、抗体、酶等生物试剂和技术服务。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-13/doc-inhxufvi4466794.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-13/doc-inhxufvi4466794.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629066660","title":"百普赛斯（301080）2026年一季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2629066660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629066660?lang=zh_cn&edition=full","pubTime":"2026-04-22 06:21","pubTimestamp":1776810097,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期百普赛斯发布2026年一季报。根据财报显示，百普赛斯营收净利润同比双双增长。截至本报告期末，公司营业总收入2.36亿元，同比上升26.33%，归母净利润4625.71万元，同比上升13.99%。本次财报公布的各项数据指标表现一般。然而去年的净利率为19.67%，算上全部成本后，公司产品或服务的附加值高。持有百普赛斯最多的基金为国投瑞银医疗保健混合A，目前规模为1.05亿元，最新净值1.0582，较上一交易日下跌1.0%，近一年上涨21.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042200011797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628294577","title":"百普赛斯（301080）披露2025年年度报告，4月20日股价下跌1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628294577","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628294577?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:11","pubTimestamp":1776694280,"startTime":"0","endTime":"0","summary":"截至2026年4月20日收盘，百普赛斯报收于47.5元，较前一交易日下跌1.17%，最新总市值为79.41亿元。该股当日开盘47.89元，最高48.7元，最低47.33元，成交额达1.7亿元，换手率为2.83%。近日，北京百普赛斯生物科技股份有限公司披露《2025年年度报告》。公告显示，公司2025年实现营业收入838,117,619.38元，同比增长29.94%；归属于上市公司股东的净利润为165,567,564.71元，同比增长33.70%；归属于上市公司股东的扣除非经常性损益的净利润为156,021,882.21元，同比增长30.98%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000036613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628198747","title":"百普赛斯(301080.SZ)发布一季度业绩，归母净利润4625.71万元，增长13.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628198747","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628198747?lang=zh_cn&edition=full","pubTime":"2026-04-20 19:36","pubTimestamp":1776684976,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百普赛斯(301080.SZ)发布2026年第一季度报告，该公司营业收入为2.36亿元，同比增长26.33%。归属于上市公司股东的净利润为4625.71万元，同比增长13.99%。归属于上市公司股东的扣除非经常性损益的净利润为4630.55万元，同比增长21.37%。基本每股收益为0.2767元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1430835.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百普赛斯(301080.SZ)发布一季度业绩，归母净利润4625.71万元，增长13.99%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624551926","title":"4月3日百普赛斯跌6.08%，广发稳健回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2624551926","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624551926?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:17","pubTimestamp":1775204262,"startTime":"0","endTime":"0","summary":"证券之星消息，4月3日百普赛斯跌6.08%，收盘报45.56元，换手率5.36%，成交量6.76万手，成交额3.14亿元。重仓百普赛斯的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为广发基金的广发稳健回报混合A。广发稳健回报混合A目前规模为33.27亿元，最新净值0.8992，较上一交易日下跌0.51%，近一年上涨10.79%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040300031332.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301080"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621808699","title":"股市必读：百普赛斯（301080）今年截至3月23日累计跌幅已超25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621808699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621808699?lang=zh_cn&edition=full","pubTime":"2026-03-24 02:39","pubTimestamp":1774291150,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，百普赛斯报收于39.57元，下跌4.77%，换手率2.62%，成交量3.3万手，成交额1.33亿元。交易信息汇总股价提醒3月23日百普赛斯收盘报39.57元，跌4.77%，当日成交330.07万元。根据收盘数据统计，该股已连续3日下跌，当年累计跌幅25.74%。该股最近90天内共有2家机构给出评级，买入评级2家；过去90天内机构目标均价为74.25。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400002408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620220075","title":"股市必读：百普赛斯（301080）今年截至3月19日累计跌幅已超20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620220075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620220075?lang=zh_cn&edition=full","pubTime":"2026-03-20 01:32","pubTimestamp":1773941532,"startTime":"0","endTime":"0","summary":"截至2026年3月19日收盘，百普赛斯报收于42.24元，下跌3.8%，换手率2.79%，成交量3.52万手，成交额1.5亿元。当日关注点来自交易信息汇总：3月19日百普赛斯收盘报42.24元，跌3.8%，当日成交351.57万元，该股当年累计跌幅20.97%。来自交易信息汇总：近90天内共有2家机构给予百普赛斯买入评级，目标均价为74.25元。来自资金流向：3月19日主力资金净流出1291.11万元，散户资金净流入1480.36万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000001534.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609556500","title":"百普赛斯冲刺港股：9个月营收6亿利润1.3亿 陈宜顶控制41%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2609556500","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609556500?lang=zh_cn&edition=full","pubTime":"2026-02-06 13:30","pubTimestamp":1770355826,"startTime":"0","endTime":"0","summary":"北京百普赛斯生物科技股份有限公司（简称：“百普赛斯”）日前递交招股书，准备在港交所上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260206/6390598141475960344839469.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20260206/6390598141475960344839469.jpeg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n32598/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["301080","VT","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608854885","title":"2月2日百普赛斯跌6.52%，广发稳健回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608854885","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608854885?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:56","pubTimestamp":1770022609,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日百普赛斯跌6.52%，收盘报52.02元，换手率3.81%，成交量4.8万手，成交额2.56亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共17家，其中持有数量最多的公募基金为广发基金的广发稳健回报混合A。广发稳健回报混合A目前规模为33.27亿元，最新净值0.9303，较上一交易日下跌0.75%，近一年上涨17.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023830.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607117036","title":"百普赛斯（301080）披露2025年度业绩预告，1月29日股价下跌1.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607117036","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607117036?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:57","pubTimestamp":1769698630,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，百普赛斯报收于57.51元，较前一交易日下跌1.15%，最新总市值为96.14亿元。该股当日开盘57.35元，最高59.37元，最低56.23元，成交额达1.94亿元，换手率为2.67%。百普赛斯于2026年1月29日披露《2025年度业绩预告》。本次业绩预告未经审计，由公司财务部门初步测算。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900044033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301080","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607084715","title":"百普赛斯(301080.SZ)发预增，预计2025年度归母净利润1.6亿元至1.9亿元，同比增长29.21%至53.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607084715","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607084715?lang=zh_cn&edition=full","pubTime":"2026-01-29 20:24","pubTimestamp":1769689499,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百普赛斯(301080.SZ)披露2025年度业绩预告，公司预计归属于上市公司股东的净利润1.6亿元至1.9亿元，同比增长29.21%至53.43%;扣除非经常性损益后的净利润1.55亿元至1.85亿元，同比增长30.13%至55.31%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399354.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"百普赛斯(301080.SZ)发预增，预计2025年度归母净利润1.6亿元至1.9亿元，同比增长29.21%至53.43%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301080"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783263065449,"stockEarnings":[{"period":"1week","weight":0.1183},{"period":"1month","weight":0.2838},{"period":"3month","weight":0.0905},{"period":"6month","weight":-0.08},{"period":"1year","weight":-0.0396},{"period":"ytd","weight":-0.08}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0099},{"period":"3month","weight":0.0421},{"period":"6month","weight":0.0188},{"period":"1year","weight":0.1683},{"period":"ytd","weight":0.0188}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京百普赛斯生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"17594人(较上一季度增加67.64%)","perCapita":"7180股","listingDate":"2021-10-18","address":"北京市大兴区北京经济技术开发区宏达北路8号4幢4层","registeredCapital":"16717万元","survey":" 北京百普赛斯生物科技股份有限公司的主营业务是专业提供重组蛋白、抗体等关键生物试剂产品及技术服务。公司的主要产品是重组蛋白、技术服务、抗体、试剂盒、磁珠。","listedPrice":112.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百普赛斯(301080)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百普赛斯(301080)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百普赛斯,301080,百普赛斯股票,百普赛斯股票老虎,百普赛斯股票老虎国际,百普赛斯行情,百普赛斯股票行情,百普赛斯股价,百普赛斯股市,百普赛斯股票价格,百普赛斯股票交易,百普赛斯股票购买,百普赛斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百普赛斯(301080)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百普赛斯(301080)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}